From code to cure: Harnessing AI for antibiotic discovery and design
Science Translational Medicine · 14.10.2026 · 18 (871)
DOI: 10.1126/scitranslmed.aee4629 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Translational Medicine, erschienen am 14.10.2026. Verfasst von Aarti Krishnan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Engineering & Science and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Discovery, Drug Design, Artificial Intelligence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Defense Threat Reduction Agency, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Artificial intelligence (AI) now enables the exploration of vast chemical and sequence spaces, the design of synthesizable antibiotics, and the prioritization of safe, mechanism-diverse candidates through integrated modeling and accelerated testing. Here, we survey recent advances in AI for both small-molecule and peptide antimicrobial drugs, highlight emerging data and reporting standards, and outline translational pathways and regulatory hurdles needed to bring these agents to patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Medical Engineering & Science and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA.
- Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Machine Biology Group, Departments of Psychiatry and Microbiology, Institute for Biomedical Informatics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Ph…
- Departments of Bioengineering and Chemical and Biomolecular Engineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Aarti Krishnan, James J Collins, Cesar de la Fuente-Nunez
Förderung
- Defense Threat Reduction Agency
- Ministry of Science and ICT, South Korea
Zitieren
APA
Krishnan, A., Cao, H., Collins, J. J., & de la Fuente-Nunez, C. (2026). From code to cure: Harnessing AI for antibiotic discovery and design. Science Translational Medicine, 18(871). https://doi.org/10.1126/scitranslmed.aee4629
Vancouver
Krishnan A, Cao H, Collins JJ, de la Fuente-Nunez C. From code to cure: Harnessing AI for antibiotic discovery and design. Science Translational Medicine. 2026;18(871). doi:10.1126/scitranslmed.aee4629
BibTeX
@article{Krishnan2026,
author = {Krishnan, Aarti and Cao, Hanqun and Collins, James J and de la Fuente-Nunez, Cesar},
title = {From code to cure: Harnessing AI for antibiotic discovery and design},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {871},
doi = {10.1126/scitranslmed.aee4629}
}
EUVIMED